About this trial
This study has to objective to assess, in adults' patients needing tracheal intubation because of vital distress, the effect of a combined strategy to reduce intubation-related morbidity. This strategy will associate systematic use of rocuronium as paralyzing agent to facilitate tracheal intubation, bag face-mask ventilation before intubation and Gum Elastic Bougie (GEB) use.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient adult (≥ 18 years) presenting with vital distress requiring emergency tracheal intubation as assessed by the emergency physician in the out-of-hospital setting.
Patient with all conditions (trauma, dyspnea, coma, overdoses, and shock) except those in cardiac arrest will be included.
Disqualifiers
Patient presenting of a contraindication to succinylcholine, and/or rocuronium, and/or sugammadex (rocunorium antagonist).
Patient who have contraindication to bag face mask ventilation before intubation (ongoing emesis, hematemesis, or hemoptysis).
Patient that are not members of a medical aid scheme (beneficiary or main member).
Patient under specific protection measures: pregnant, parturient or nursing women; legal protection or deprived of liberty: patient under judicial protection, patient under guardianship/curatorship.
Trial design
Parallel
Treatments tested in this trial
Data patient
Other interventionMedical History and characteristic of patient
Physical examination
Other interventionArterial pressure, arterial oxygen saturation, heart rate
Rapid sequence intubation (RSI) : Rocuronium /Bag-mask ventilation /GEB
Procedure/SurgeryRapid sequence intubation (RSI) will be performed with use of rocuronium as paralytic agent (1.2 mg/ kg). Bag-mask ventilation between induction and laryngoscopy will be performed. The GEB will be systematically used at the first attempt to facilitate intubation.
Rapid sequence intubation (RSI) : Recommendations for emergency intubation
Procedure/SurgeryRapid sequence intubation (RSI) using succinylcholine as a paralytic agent (1 mg/kg), no systematic bag-mask ventilation between induction and laryngoscopy, use of GEB to facilitate intubation in case of intubation failure under direct laryngoscopy.
Treatment groups
Trial outcomes
Primary outcomes
Severe intubation-related complications occurring during the first hour after intubation
Proportion of patients with severe intubation-related complications occurring during the first hour after intubation The severe intubation-related complications are: * Cardiac arrest. * At least one arterial hypotension episode defined by systolic blood pressure\<90 mmHg. * At least one hypoxemia episode defined by an occurrence of a new episode of oxygen. * Saturation \< 90%. * Severe cardiac arrhythmia: ventricular tachycardia. * Pulmonary aspiration, reported by the physician. * Esophageal intubation. * Unintentional extubation. Severe intubation-related complications will be recorded by the emergency physician in charge of the patient.
Secondary outcomes
Difficulty of the intubation process - Intubation Difficulty
Intubation Difficulty Score (IDS). minimum values is 0 and the maximum values is dependent on the added elements.
Difficulty of the intubation process - Intubation conditions assessed by the Copenhagen
Intubation conditions assessed by the Copenhagen score - The value is clinically not acceptable and clinical acceptable
Difficulty of the intubation process - Alternative techniques.
Proportion of patients intubated by alternative techniques.
Difficulty of the intubation process - Intubation attempts
Mean number of intubation attempts
Sponsors and contacts
Click on the lead sponsor to view all of their trials.